Les Rendez-vous Audace
Since 2014, IRIC has been organizing the Audacious benefit event, which annually contributes to funding breakthroughs in the fight against cancer. Exceptionally this year, the Institute is offering you a new virtual formula that is just as promising, free of charge, with a view to democratizing science.
Audacious is therefore making way for Les Rendez-vous Audace, a series of 3 fascinating and resolutely daring conferences revolving around an inspiring theme: Le temps d’une découverte.
This series is divided into 3 chapters:
- IRIC: from a vision to a revolution
- AI: an engine for accelerating research
- From the lab to the patient: the crucial stages of research
These conferences are offered in french.
To confirm your sponsorship, download the confirmation form.
Please note that a company can obtain a personalized sponsorship. Please contact Anne Lebel: audace@iric.ca, 514 343-6141
Le temps d’une découverte
The crisis we are going through presents us with many challenges. It also provides us with a great lesson and reminds us of the importance of supporting scientific research. We are now fully aware of the time and effort it takes to make a discovery that could make a difference.
Cancer research has advanced considerably in recent years. A real revolution is underway! It’s all a matter of time and funding to make new discoveries.
Research time is accelerating thanks to incredible innovations. New therapeutic solutions have thus been developed and have changed the lives of many patients affected by the disease. Hope grows.
Les Rendez-vous Audace invites you to take the time to discover our Institute. You will learn that at IRIC, we do things differently. We are speeding up the equation from research to therapy. Since its creation, the Institute has taken charge of changing the landscape of cancer research and acts as a leader in the training of emerging researchers, the genesis of new knowledge and the discovery of therapies. To achieve different results – to better understand, seek, find and treat cancer – IRIC is forging its own path.
So take the time to come and discover the work of women and men who have the strength to dream big and defy time to accelerate the discovery of better therapies for cancer patients.
IRIC: from a vision to a revolution
April 13, 2021
From 12:00 pm to 1:00 pm
The research efforts carried out at IRIC for nearly 20 years are the result of the unique vision of the founders of the Institute and the boundless determination of the 29 research teams. Some would say that spectacular advances in oncology are at the heart of a real revolution.
How has research changed over the past few years? What is the winning recipe for making a discovery? What can we expect for cancer patients in the near future?
Come hear the Rector of the Université de Montréal, Mr. Daniel Jutras, in conversation with the founder of IRIC, Guy Sauvageau, also hematologist and Principal Investigator at IRIC.
Link: Conférence 1 – L’IRIC : d’une vision vers une révolution
AI: an engine for accelerating research
April 20, 2021
From 12:00 pm to 1:00 pm
In recent years, IRIC has been confronted with the amount of massive data generated by new technologies. Faced with this reality, the Institute has chosen to acquire, in partnership with the Montreal artificial intelligence ecosystem, remarkable expertise in bioinformatics and biomedical data.
Is AI transforming the way we think about traditional research? How does it apply to the field of cancerology? Does it really have the potential to accelerate discovery for the benefit of patients?
Do not miss this conference by Sébastien Lemieux, Principal Investigator at IRIC, accompanied by Yoshua Bengio, Scientific Director of the Quebec Artificial Intelligence Institute (Mila).
Link: Conférence 2 – L’IA : un moteur d’accélération de la recherche
From the lab to the patient: the crucial stages of research
April 27, 2021
From 12:00 pm to 1:00 pm
It sometimes seems like it takes forever to develop a promising treatment. There are many steps from basic research to discovering therapies and the road is often strewn with pitfalls.
But why does it take so long to develop a treatment? What are the challenges faced by the various stakeholders? Has laboratory research borne fruit at IRIC in recent years?
Be there for this discussion between Anne Marinier, Principal Investigator, Director of the Drug Discovery Unit at IRIC, and Guy Sauvageau, Principal Investigator at IRIC and also hematologist at the HMR.
Link: Conférence 3 – Du labo au patient : les étapes cruciales de la recherche
Thank you to our sponsors!
